Spire Wealth Management Astrazeneca PLC Transaction History

Spire Wealth Management

$2.7 Billion
Q2 2025

A detailed history of Spire Wealth Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Spire Wealth Management holds 6,228 shares of AZN stock, worth $522,342. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,228

Previous 7,065 11.85%

Holding current value

$522,342

Previous $519,000 16.18%

% of portfolio

0.02%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	SELL	$64.87 - $75.0 $54,296 - $62,775	-837 Reduced 11.85%	6,228 $435,000
Q1 2025 Apr 23, 2025	BUY	$65.37 - $77.96 $44,386 - $52,934	679 Added 10.63%	7,065 $519,000
Q4 2024 Jan 24, 2025	SELL	$63.2 - $79.58 $22,183 - $27,932	-351 Reduced 5.21%	6,386 $418,000
Q3 2024 Oct 15, 2024	SELL	$76.67 - $87.62 $13,953 - $15,946	-182 Reduced 2.63%	6,737 $524,000
Q2 2024 Jul 31, 2024	SELL	$66.81 - $80.83 $10,355 - $12,528	-155 Reduced 2.19%	6,919 $539,000
Q1 2024 Apr 24, 2024	SELL	$61.03 - $69.57 $33,505 - $38,193	-549 Reduced 7.2%	7,074 $479,000
Q4 2023 Feb 06, 2024	SELL	$61.89 - $69.28 $22,404 - $25,079	-362 Reduced 4.53%	7,623 $513,000
Q3 2023 Nov 08, 2023	SELL	$64.85 - $71.7 $21,076 - $23,302	-325 Reduced 3.91%	7,985 $540,000
Q2 2023 Aug 09, 2023	BUY	$69.91 - $75.81 $14,820 - $16,071	212 Added 2.62%	8,310 $594,000
Q1 2023 May 09, 2023	SELL	$63.15 - $71.6 $7,767 - $8,806	-123 Reduced 1.5%	8,098 $562,000
Q4 2022 Feb 03, 2023	BUY	$54.21 - $70.44 $2,602 - $3,381	48 Added 0.59%	8,221 $557,000
Q3 2022 Nov 07, 2022	BUY	$53.02 - $135.75 $15,110 - $38,688	285 Added 3.61%	8,173 $448,000
Q2 2022 Jul 22, 2022	SELL	$59.26 - $71.14 $138,135 - $165,827	-2,331 Reduced 22.81%	7,888 $521,000
Q1 2022 Apr 18, 2022	SELL	$55.72 - $67.12 $125,314 - $150,952	-2,249 Reduced 18.04%	10,219 $678,000
Q4 2021 Jan 14, 2022	BUY	$54.02 - $63.83 $144,503 - $170,745	2,675 Added 27.32%	12,468 $726,000
Q3 2021 Oct 22, 2021	BUY	$55.56 - $60.79 $4,889 - $5,349	88 Added 0.91%	9,793 $588,000
Q2 2021 Jul 26, 2021	SELL	$48.42 - $60.18 $207,237 - $257,570	-4,280 Reduced 30.6%	9,705 $581,000
Q1 2021 May 21, 2021	BUY	$47.16 - $54.44 $659,532 - $761,343	13,985 New	13,985 $523,000

Others Institutions Holding AZN

# of Institutions

1,421

Shares Held

498M

Call Options Held

7.11M

Put Options Held

2.57M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $260B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.

Account

Spire Wealth Management Astrazeneca PLC Transaction History